Clinical trial
Health Effects of SLT, Cigarette Smoking, and New Tobacco Products
NCT00469079 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00469079 |
|---|---|
| Title | Health Effects of SLT, Cigarette Smoking, and New Tobacco Products |
| Official title | Comparing the Health Effects of Smokeless Tobacco, Cigarette Smoking, and New Tobacco Products Advertised as Safer Alternatives Part of Tobacco Exposure Reduction |
| Acronym | ANTS3 |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Cancer Institute (NCI) NIH National Institute on Drug Abuse (NIDA) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nicotine Dependence |
| Intervention type | Drug, Other |
| Interventions | Nicotine gum and lozenge, Taboka, Camel Snus |
| Enrollment | 130 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | May 4, 2007 |
| Last update posted | Nov 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: